About the Company
We do not have any company description for Metagenomi, Inc. at the moment.
Exchange
Nasdaq
Fundamental Data and Insider Transactions (Quarterly data) Full Screen
Loading the fundamentals chart...
Latest News on Metagenomi, Inc.
Metagenomi, Inc. Welcomes Eric Bjerkholt to Board of Directors
Metagenomi, Inc., a precision genetic medicines company, announced that Eric Bjerkholt, CFO of Mirum Pharmaceuticals, will join its Board of Directors effective January 27, 2025.
Metagenomi, Inc. Sued for Securities Law Violations - Morningstar
Metagenomi, Inc. Sued for Securities Law Violations - Investors Should Contact The Gross Law Firm Before November 25, 2024 to Discuss Your Rights - MGX PR Newswire NEW YORK, Oct. 31, 2024 ...
Metagenomi, Inc.: A Buy Rating for Pioneering Gene Editing Advancements
Metagenomi, Inc.: A Buy Rating for Pioneering Gene Editing Advancements TipRanks Mar. 5, 2024, 04:45 AM ...
Analysts Have Been Trimming Their Metagenomi, Inc. (NASDAQ:MGX) Price Target After Its Latest Report
Metagenomi, Inc. (NASDAQ:MGX) just released its latest quarterly results and things are looking bullish. The results overall were credible, with revenues of US$8.5m beating expectations by 10%.
MGX Investors Have Opportunity to Lead Metagenomi, Inc. Securities ...
NEW YORK, Oct. 22, 2024 /PRNewswire/ -- Rosen Law Firm, a global investor rights law firm, reminds purchasers of stock of Metagenomi, Inc. (NASDAQ: MGX) pursuant and/or traceable to the Company's ...
Metagenomi, Inc. (MGX): This New Penny Stock Received a Positive Rating ...
Metagenomi, Inc. (NASDAQ:MGX), a company situated in Emeryville, California, was established with the goal of developing a “comprehensive genome editing toolbox” that would aid in the genetic ...
Metagenomi, Inc. CEO Brian C. Thomas to Present at 43rd Annual J.P ...
Metagenomi, Inc., a company focused on precision genetic medicines, announced that its CEO and founder, Brian C. Thomas, PhD, will present at the 43rd Annual J.P. Morgan Healthcare Conference on ...
Metagenomi Appoints Laurence Reid, PhD to its Board of Directors
Dr. Reid brings 30 years of experience in building biotech companies based on innovative scientific platforms and shaping ...
Metagenomi, Inc. Sued for Securities Law Violations - Investors Should ...
Metagenomi completed its initial public offering on February 13, 2024, selling 6.25 million shares at $15 per share. However, less than three months later, on May 1, 2024, Metagenomi announced ...
Metagenomi, Inc. Sued for Securities Law Violations - Contact The Gross ...
In response to the news, Metagenomi's stock price declined from $7.04 per share on May 1, 2024 to $6.17 per share on May 2, 2024.
Similar Companies
Loading the latest forecasts...